In recent years, with the increase in published data, new implemented therapies, new forms of insulin, and increasing access to glucose monitoring systems, the need for specific CF criteria and cut-off value for the early diagnosis of glucose metabolism alteration has emerged. Here, INS is linked to cystic fibrosis.